Specialties – Page 69

How to Improve the Quality of Your Sex Life: 6 Methods and 8 Tips for Passionate Intimacy

By MedXY 08/15/2025

Explore methods to enhance the quality of your sex life and ignite passion with practical tips and advice for couples.

Family Medicine & Nutrition news Specialties

Unveiling Surprising Insights into Sexual Health: Facts Everyone Should Know

By MedXY 08/15/2025

Explore lesser-known but scientifically-backed facts about sexual health that challenge common myths and promote better understanding between genders for enhanced well-being.

Cardiology Family Medicine & Nutrition news Specialties

Healthy Eating for the Planet: Linking Sustainable Diets with Reduced Cardiovascular Risk and Longevity

By MedXY 08/15/2025

Observational evidence from over 13,000 US adults reveals that adherence to the environmentally sustainable EAT-Lancet diet is associated with significantly reduced risks of cardiovascular disease, cardiovascular mortality, and all-cause mortality over nearly 30 years.

news Oncology Specialties

Adagrasib vs Docetaxel in KRASG12C-Mutated NSCLC: New Hope from KRYSTAL-12 Phase 3 Trial

By MedXY 08/15/2025

The KRYSTAL-12 trial demonstrated that adagrasib significantly improves progression-free survival compared to docetaxel in previously treated KRASG12C-mutated advanced NSCLC, with manageable safety profiles.

Infectious Diseases news Public Health Specialties

Long-term Safety and Efficacy of Rabies Monoclonal Antibody and Vaccine for Post-Exposure Prophylaxis: Insights from a Phase 4 Trial in India

By MedXY 08/15/2025

A phase 4 randomized trial demonstrates that combining rabies monoclonal antibody with vaccine in category 3 exposures is safe, immunogenic, and effective in preventing rabies up to one year post-exposure.

Gastroenterology General Surgery news Specialties

Five-Year Outcomes of Per-Oral Endoscopic Myotomy vs. Laparoscopic Heller’s Myotomy Plus Dor Fundoplication in Idiopathic Achalasia

By MedXY 08/14/2025

A multicenter randomized trial shows POEM is non-inferior to LHM plus Dor fundoplication for achalasia symptom control at 5 years, with differing reflux profiles.

Gastroenterology news Specialties

Durable Remission and Safety of Upadacitinib in Moderate to Severe Ulcerative Colitis: Insights from the Phase 3 U-ACTIVATE Long-Term Extension Interim Analysis

By MedXY 08/14/2025

Interim data from the U-ACTIVATE study demonstrate sustained clinical and endoscopic remission and a consistent safety profile for upadacitinib up to 3 years in moderate to severe ulcerative colitis.

Clinical Updates General Surgery Oncology Specialties

Advancing Organ Preservation in Locally Advanced Rectal Cancer: Insights from the CAO/ARO/AIO-16 Phase 2 Trial

By MedXY 08/14/2025

Total neoadjuvant therapy combined with watch-and-wait strategies achieves a 37% clinical complete response rate in locally advanced rectal cancer with manageable toxicity, offering an organ-preserving alternative to surgery.

Gastroenterology General Surgery news Specialties

Endoscopic Ultrasound-Guided Gastroenterostomy Reduces Reintervention in Malignant Gastric Outlet Obstruction: Insights from the Multicentre DRA-GOO Trial

By MedXY 08/14/2025

A multicentre RCT demonstrated that endoscopic ultrasonography-guided gastroenterostomy (EUS-GE) significantly lowers 6-month reintervention rates and improves gastric outlet obstruction symptoms compared to duodenal stenting in unresectable malignant gastric outlet obstruction.

Emergency Medicine Family Medicine & Nutrition news Specialties

Frailty as a Predictor of Post-Hospital Outcomes in Older Adults: Implications for Discharge Planning and Care

By MedXY 08/14/2025

Frailty in older hospitalized adults is strongly linked to discharge to post-acute care, increased 90-day readmission rates, and higher mortality, highlighting the need for targeted discharge planning using automated frailty assessments.

news Public Health Specialties

Workplace Violence in Urban and Rural Hospitals: A Growing Threat with High Costs

By MedXY 08/14/2025

Workplace violence in American hospitals causes significant trauma, financial costs, and operational challenges, affecting both urban and rural hospitals equally, despite differences in available resources. Prevention and trauma-informed response are critical.

Clinical Updates Gastroenterology news Specialties

Etrasimod in the Management of Eosinophilic Oesophagitis: Promising Results from the VOYAGE Phase 2 Trial

By MedXY 08/14/2025

The VOYAGE phase 2 trial demonstrated that etrasimod, an oral S1P receptor modulator, significantly reduces oesophageal eosinophilic inflammation and improves endoscopic findings in adults with eosinophilic oesophagitis, with a favorable safety profile over 52 weeks.

General Surgery news Oncology Specialties

Intraoperative Indocyanine Green Fluorescence Angiography in Rectal Cancer Surgery: Insights from the IntAct Trial

By MedXY 08/14/2025

The IntAct randomized trial investigated whether intraoperative indocyanine green (ICG) fluorescence angiography reduces clinical anastomotic leaks after rectal cancer surgery, showing a trend toward leak reduction but no statistically significant benefit.

Family Medicine & Nutrition Gastroenterology news Specialties

Examining the Role of Gluten and Wheat in Irritable Bowel Syndrome: Insights from a Double-Blind, Sham-Controlled Crossover Trial

By MedXY 08/14/2025

A rigorous trial reveals that perceived symptom worsening from gluten or wheat in IBS patients may largely be driven by expectation rather than the substances themselves, underscoring the importance of distinguishing true sensitivities from placebo effects.

Gastroenterology General Surgery news Specialties

Appendicectomy Plus Medical Therapy Significantly Reduces Relapse in Ulcerative Colitis: Insights from the ACCURE Trial

By MedXY 08/14/2025

The ACCURE trial demonstrates that laparoscopic appendicectomy combined with standard medical therapy significantly lowers 1-year relapse rates compared to medical therapy alone in ulcerative colitis patients in remission.

Clinical Updates Diabetes & Endocrinology news Specialties Urology

SGLT2 Inhibitors Lower Mortality Risk Post-UTI in Diabetes

By MedXY 08/14/2025

Recent research indicates that patients with type 2 diabetes who use SGLT2 inhibitors after a urinary tract infection have a lower mortality risk compared to those using DPP-4 inhibitors.

AI Medical News news Specialties

Oracle Health Launches AI-First, Voice-Enabled EHR to Enhance Clinician Experience and Compete with Epic

By MedXY 08/14/2025

Oracle Health unveils a next-generation AI-powered, voice-first electronic health record (EHR) system designed from the ground up to improve clinical workflow and challenge Epic’s market dominance in the U.S. acute care sector.

AI news Specialties

10 Ways AI is Transforming Healthcare

By MedXY 08/14/2025

Explore how AI is revolutionizing healthcare by enhancing diagnostics, predicting diseases, and supporting medical professionals in various capacities.

AI Gastroenterology news Specialties

AI in Colonoscopy: Enhancing Detection or Eroding Physician Skills?

By MedXY 08/13/2025

The integration of AI in colonoscopy improves adenoma detection but raises concerns about declining physician skills when AI support is withdrawn, highlighting a potential clinical 'de-skilling' effect.

AI Cardiology news Specialties

Leveraging AI-Driven Care to Significantly Reduce Heart Failure Readmissions: The Linea Model

By MedXY 08/13/2025

Linea integrates generative AI and high-touch virtual nursing to proactively manage heart failure patients, achieving a 50% reduction in hospital readmissions within 90 days, substantially lowering costs and improving patient outcomes.